197

Drug Discovery
Sub Categories on Drug Discovery
{{items.name}}
Latest Articles
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

by Sujith Ramachandran, Adam Pate,The ConversationCredit: Unsplash/CC0 Public DomainEven when Americans have health insurance, they can have a hard timeaffording the drugs they've been prescribed.
Updated on: January 28,2026
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

by Sujith Ramachandran, Adam Pate,The ConversationCredit: Unsplash/CC0 Public DomainEven when Americans have health insurance, they can have a hard timeaffording the drugs they've been prescribed.
Updated on:January 28,2026
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
Updated on: December 27,2025
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
Updated on:December 27,2025
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum
Updated on: February 04,2026
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum
Updated on:February 04,2026
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com